ClinicalTrials.gg
Not yet recruitingNCT07878858POSE-SBPUpdated Oct 16, 2026

Equivalence of Systolic Blood Pressure Measurements Between Fowler and Seated Positions

An interventional study of body position in Blood Pressure Measurement, sponsored by Iuliu Hatieganu University of Medicine and Pharmacy. Not yet recruiting at 2 sites in Romania. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-16.

Sponsored by Iuliu Hatieganu University of Medicine and Pharmacy · Not applicable, Interventional, and Other

Updated Oct 16, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Blood pressure is an important part of checking heart health. Blood pressure is usually measured while sitting, but in everyday medical care it is sometimes measured in other positions, such as the Fowler position, where the upper body is raised. This study will compare blood pressure measured while sitting with blood pressure measured in the Fowler position to see whether the results are similar enough to be considered equivalent. Adults aged 18 or older who can give informed consent and have an arm circumference of 22-42 cm may take part. Each participant will have their blood pressure measured in both positions, with the order chosen randomly. People who cannot maintain the required positions or whose condition could affect the accuracy of the blood pressure measurement will not take part.

Read the detailed description

Background and Rationale Blood pressure (BP) measurement is a cornerstone of cardiovascular assessment. Standard guidelines recommend seated BP measurements; however, in routine clinical practice, measurements are frequently obtained in alternative positions such as the Fowler position. This study aims to determine whether SBP measurements obtained in the Fowler position are clinically equivalent to those obtained in the seated position.

Objectives The primary objective is to determine whether SBP measured in the Fowler position is equivalent to SBP measured in the seated position within a predefined clinical equivalence margin of ±5 mmHg.

Hypothesis Null hypothesis: The mean paired difference in SBP between Fowler and seated positions is outside the equivalence margin of ±5 mmHg.

Alternative hypothesis: The mean paired difference in SBP between Fowler and seated positions lies within the equivalence margin of ±5 mmHg.

Study Design This is a prospective, randomized, paired equivalence trial. Each participant will undergo SBP measurement in both seated and Fowler positions, with the order of positions randomized.

Setting Outpatient cardiology clinic. Blood Pressure Measurement Protocol Blood pressure will be measured using a validated automated OMRON device. For each position, three consecutive (1 minute apart) SBP measurements will be obtained and averaged. A rest period of 5 minutes will be observed after changing position before measurements, with a 5-minute rest period before the first BP measurement. The same arm and appropriately sized cuff will be used for all measurements.

Seated position

  • Back supported
  • Feet flat on the floor
  • Legs uncrossed
  • Arm supported at mid-sternal (right atrial) level Fowler position
  • Semi-recumbent position with trunk elevated at 30° measured using an inclinometer
  • Knees extended
  • Back supported

Randomization Participants will be randomized 1:1 to one of two measurement sequences: (1) seated first followed by Fowler, or (2) Fowler first followed by seated. The method used is random block generation, to account for the relatively small size of the study population.

Outcome Measure Primary outcome: Mean paired difference in systolic blood pressure between Fowler and seated positions.

Sample Size Calculation Assuming a standard deviation of paired differences of 9 mmHg, an equivalence margin of ±5 mmHg, a two-sided alpha of 0.01, and 95% power, a minimum of 120 participants is required. This will yield 240 observations between the two positions.

Statistical Analysis Analyses will be performed according to a per-protocol principle, as recommended for equivalence trials.

The mean paired difference (Fowler - seated, seated - Fowler) will be calculated for each participant.

Equivalence will be assessed using the TOST procedure. A 99% confidence interval (CI) for the mean paired SBP difference will be constructed. Equivalence will be concluded if the entire CI lies within the predefined equivalence margin of ±5 mmHg.

Normality of paired differences will be evaluated using the Shapiro-Wilk test. If violated, bootstrap confidence intervals (10,000 resamples) will be used.

All tests will be two-sided with significance level α = 0.01. Ethical Considerations The study will be conducted in accordance with the Declaration of Helsinki. All participants will provide written informed consent prior to participation.

Data Management Data will be collected anonymously and stored securely. Only study investigators will have access to the final dataset.

02

Conditions studied

  • Blood Pressure Measurement

Keywords

  • blood pressure
  • methodology
  • equivalence
03

In context

Lead sponsor

Iuliu Hatieganu University of Medicine and Pharmacy is the lead sponsor of 55 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged ≥18 years
  • Arm circumference 22-42 cm
  • Ability to provide informed consent

Exclusion criteria

Exclusion Criteria:

  • Inability to maintain required positions
  • Pregnancy
  • Any condition interfering with accurate BP measurement (i.e., atrial fibrillation)
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Active comparator
    Seated BP

    standardised BP measurement

    Other: body position

  • Experimental
    Fowler BP

    BP measurement in the fowler position

    Other: body position

Interventions

  • Otherbody position

    Body position relevance for the assessment of blood pressure

06

What researchers measure

Primary outcomes

  1. Mean paired difference in systolic blood pressure

    Primary outcome: Mean paired difference in systolic blood pressure between Fowler and seated positions.

    Time frame: 25-30 minutes

07

Study locations

2 sites
  • Centrul Medical Transilvania
    Cluj-Napoca, Cluj 40034, Romania
  • Spitalul Clinic Judetean de Urgenta Cluj
    Cluj-Napoca, Cluj 40034, Romania
08

References and documents

Publications

  • Cicolini G, Pizzi C, Palma E, Bucci M, Schioppa F, Mezzetti A, Manzoli L. Differences in blood pressure by body position (supine, Fowler's, and sitting) in hypertensive subjects. Am J Hypertens. 2011 Oct;24(10):1073-9. doi: 10.1038/ajh.2011.106. Epub 2011 Jun 16. PubMed 21677699 ↗

Individual participant data

Plan to share: Yes — BP measurements, Demographic data, Medical History, and further data, on reasonable request

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: dec 2026- dec 2027

Access criteria: by direct request, any scientific research personnel

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 16, 2026
Show all 1 update
  1. Oct 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07878858
Lead sponsor
Iuliu Hatieganu University of Medicine and Pharmacy
Responsible party
Sponsor
First posted
Oct 16, 2026
Start date
Oct 20, 2026 (estimated)
Primary completion
Dec 10, 2026 (estimated)
Completion
Dec 20, 2026 (estimated)
Last update
Oct 16, 2026

Study contacts

Mihai Lupu, MD, PhD, Assistant Professor
Contact
lupu.mihai@umfcluj.ro
România ext. +40755022572
Mihai Lupu, MD, PhD, Assistant Professor
study chair · Iuliu Hatieganu University of Medicine and Pharmacy

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion